Bloodstream infections in a rural hospital in Sierra Leone: a retrospective database study
Journal of Medical Microbiology · 2025
DOI: 10.1099/jmm.0.002014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Henning Rottmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology, University Münster, Domagkstrasse 10, 48149 Münster, Germany. Hauptthemen laut MEDLINE: Bacteremia, Bacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Gesellschaft für Internationale Zusammenarbeit.
Abstract (Originalsprache)
Background
The health system in Sierra Leone has limited infrastructure to provide data on the epidemiology of infectious diseases and to inform clinical decision-making. The diagnostic and research laboratory capacity at Masanga Teaching Hospital was systematically expanded with microbiology infrastructure-building as one of the centrepieces.
Objective
This study aims to report the spectrum of bacterial pathogens from bloodstream infections (BSIs) in a rural hospital in Sierra Leone during the first year after the implementation of a blood culture infrastructure and characterize the detected antimicrobial resistances. Patients and methods. Patients treated at Masanga Hospital (Sierra Leone, March 2023–March 2024) were included in this database analysis if they were tested for BSI (BD BACTEC). Demographic and medical data were recorded for each patient. Antimicrobial susceptibility testing was done following EUCAST clinical guidelines.
Results
Of the 340 blood cultures, 34 (10%) were positive for obligate pathogens. The three most frequent pathogens were Escherichia coli ( n =8), followed by Burkholderia cepacia complex ( n =7) and Salmonella enterica ( n =5). Almost all Klebsiella pneumoniae ( n =3/3) and E. coli ( n =7/8) were resistant to third-generation cephalosporins. All four Staphylococcus aureus isolates were methicillin susceptible ( mecA negative). Carbapenem resistance was detected in Acinetobacter baumannii complex ( bla NDM )
Conclusion
The proportion of positive blood cultures with obligate pathogens (10%) was within the suggested benchmark (5–15%). Gram-negative bacteria dominated the pathogen spectrum of BSI with high resistance rates to third-generation cephalosporins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Microbiology, University Münster, Domagkstrasse 10, 48149 Münster, Germany.
- Masanga Medical Research Unit, Tonkolili District, Sierra Leone.
- Department of Infectious Diseases, Centre of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Netherlands, Meibergdreef 9, 1105 AZ, Amsterdam.
- Institute of Tropical Medicine & Deutsches Zentrum für Infektionsforschung, University of Tübingen, Tübingen, Germany.
- Centre de Recherches Médicales (CERMEL), Lambaréné, Gabon.
Förderung
- Deutsche Gesellschaft für Internationale Zusammenarbeit
Zitieren
APA
Rottmann, H., Olaru, I. D., Kanu, E. M., Theiler, T., Kargbo, I. M., Kalkman, L., Grobusch, M. P., & Schaumburg, F. (2025). Bloodstream infections in a rural hospital in Sierra Leone: a retrospective database study. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002014
Vancouver
Rottmann H, Olaru ID, Kanu EM, Theiler T, Kargbo IM, Kalkman L, et al. Bloodstream infections in a rural hospital in Sierra Leone: a retrospective database study. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.002014
BibTeX
@article{Rottmann2025,
author = {Rottmann, Henning and Olaru, Ioana D and Kanu, Emmanuel Marx and Theiler, Tom and Kargbo, Islam M and Kalkman, Laura and Grobusch, Martin P and Schaumburg, Frieder},
title = {Bloodstream infections in a rural hospital in Sierra Leone: a retrospective database study},
journal = {Journal of Medical Microbiology},
year = {2025},
doi = {10.1099/jmm.0.002014}
}
EUVIMED